Leukemia, Myeloid Clinical Trials

Completed

Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant

NCT00068718

Conditions: Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blood Protein Disorders, +38 more
Locations: VA Puget Sound Health Care System Seattle, Washington, United States

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

Universitaet Leipzig Leipzig, Germany

University of Torino Torino, Italy

View Trial Details

Completed

Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

NCT00397813

Conditions: Anemia, Anemia, Hemolytic, Anemia, Refractory, +40 more
Locations: LDS Hospital Salt Lake City, Utah, United States

Veterans Administration Center-Seattle Seattle, Washington, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

NCT00096161

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +42 more
Locations: Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States

LDS Hospital Salt Lake City, Utah, United States

VA Puget Sound Health Care System Seattle, Washington, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

NCT00789776

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +49 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States

Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

NCT00040846

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +164 more
Locations: Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States

Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States

LDS Hospital Salt Lake City, Utah, United States

VA Puget Sound Health Care System Seattle, Washington, United States

View Trial Details

Completed

Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission

NCT00045435

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +29 more
Locations: OHSU Cancer Institute Portland, Oregon, United States

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

NCT00089011

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +250 more
Locations: Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States

LDS Hospital Salt Lake City, Utah, United States

VA Puget Sound Health Care System Seattle, Washington, United States

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib

NCT00036738

Conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Crisis, +31 more
Locations: Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States

VA Puget Sound Health Care System Seattle, Washington, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia

NCT00342316

Conditions: Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations: Royal Prince Alfred Hospital Camperdown, New South Wales, Australia

Royal Adelaide Hospital Adelaide, South Australia, Australia

Austalasian Leukaemia &Lymphoma Group Limited East Melbourne, Victoria, Australia

Cancer Care Manitoba Winnipeg, Manitoba, Canada

View all 25 locations

View Trial Details

Completed

Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)

NCT02085798

Conditions: Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +23 more
Locations: Hospital Universitario Txagorritxu Vitoria-Gasteiz, Alava, Spain

Hospital Universitario La Ribera Alzira, Alicante, Spain

Hospital Universitari Germans Trias I Pujol Badalona, Barcelona, Spain

Complejo Hospitalrio La Mancha Centro Alcázar de San Juan, Ciudad Real, Spain

View all 50 locations

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions